Drugs That Distort Resting Heart Rate: Medications That Skew Your Reading

What Resting Heart Rate Actually Measures

Resting heart rate (RHR) reflects the balance between sympathetic drive and parasympathetic (vagal) tone on the sinoatrial node. A normal adult range is 60 to 100 bpm according to the American Heart Association, though well-conditioned athletes often sit between 40 and 60 bpm without symptoms.

The number matters. A meta-analysis published in the Canadian Medical Association Journal (N=46 studies, 1,246,203 participants) found that each 10-bpm increase in resting heart rate was associated with a 9% higher risk of cardiovascular mortality and a 6% higher risk of all-cause mortality [1]. The European Society of Cardiology identifies resting HR above 75 bpm as an independent risk factor in patients with established coronary artery disease [2]. These thresholds only mean something, though, if the reading is not being pushed around by a drug. Any medication that acts on the autonomic nervous system, the sinoatrial node directly, or thyroid hormone levels can make a single RHR measurement unreliable as a fitness or risk biomarker.

Drugs That Lower Resting Heart Rate

Beta-blockers are the most common cause of pharmacologically suppressed heart rate. Metoprolol, atenolol, propranolol, carvedilol, and bisoprolol all block beta-1 adrenergic receptors on cardiac pacemaker cells, reducing both rate and contractility. In the MERIT-HF trial (N=3,991), metoprolol succinate reduced mean resting heart rate by approximately 14 bpm compared to placebo over 12 months [3]. Propranolol, a non-selective beta-blocker, tends to produce even larger reductions because it also blocks beta-2 receptors [4].

Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) slow conduction through the AV node. Diltiazem typically lowers resting HR by 8 to 12 bpm at standard doses according to prescribing data reviewed by the FDA [5]. Verapamil can produce similar or slightly larger reductions, particularly in older adults with pre-existing sinus node dysfunction.

Ivabradine works differently. It inhibits the If ("funny") current in the sinoatrial node without touching blood pressure or contractility. In the SHIFT trial (N=6,558), ivabradine reduced resting HR by a mean of 10.9 bpm in heart failure patients already on beta-blockers [6]. This drug is specifically prescribed to lower heart rate, so its effect is not a side effect but the intended mechanism.

Digoxin enhances vagal tone and slows AV conduction. Typical HR reductions range from 10 to 25 bpm. The DIG trial (N=6,800) used target trough levels of 0.5 to 0.9 ng/mL, at which bradycardia was the most frequently reported adverse event [7].

Clonidine and other central alpha-2 agonists (guanfacine, methyldopa) reduce sympathetic outflow from the brainstem. HR reductions of 5 to 15 bpm are typical. These drugs are prescribed for hypertension, ADHD, and opioid withdrawal, so the clinical context varies widely [8].

Drugs That Raise Resting Heart Rate

Sympathomimetic stimulants produce the most predictable HR elevations. In a meta-analysis of 11 randomized trials (N=5,837), methylphenidate increased resting heart rate by a mean of 5.7 bpm in adults with ADHD [9]. Amphetamine-based formulations (Adderall, Vyvanse) tend to produce slightly higher increases, in the range of 6 to 10 bpm, though individual responses vary substantially based on dose and CYP2D6 metabolism [10].

Thyroid hormone replacement at supratherapeutic doses is a frequent and underappreciated cause of elevated RHR. Levothyroxine drives cardiac beta-receptor sensitivity upward. The American Thyroid Association guidelines note that TSH suppression below 0.1 mIU/L is associated with a 3-fold increase in atrial fibrillation risk, and resting tachycardia is often the first clinical sign [11]. Even mildly overreplaced patients (TSH 0.1 to 0.4 mIU/L) may show resting HR 8 to 15 bpm higher than their euthyroid baseline.

Anticholinergic medications raise HR by blocking muscarinic receptors on the sinoatrial node, reducing parasympathetic braking. The list is long: atropine, scopolamine, oxybutynin, tolterodine, diphenhydramine, tricyclic antidepressants (amitriptyline, nortriptyline), and first-generation antipsychotics. Amitriptyline at doses above 75 mg/day has been shown to increase resting HR by 10 to 20 bpm in some patients [12]. A study in the Journal of Clinical Psychopharmacology documented mean HR increases of 11.4 bpm with clozapine and 7.2 bpm with olanzapine at therapeutic doses [13].

Short-acting bronchodilators (albuterol, levalbuterol) activate beta-2 receptors in the lungs but also stimulate cardiac beta-1 receptors at higher doses. Post-nebulizer HR increases of 10 to 20 bpm are common and may persist for 30 to 60 minutes [14].

Decongestants containing pseudoephedrine or phenylephrine raise HR through peripheral alpha-1 agonism and indirect sympathomimetic effects. An FDA safety review flagged cardiovascular effects as a concern, particularly in patients already on stimulant medications [15].

GLP-1 Receptor Agonists and Heart Rate

GLP-1 receptor agonists deserve a separate discussion because they are increasingly prescribed for weight management and type 2 diabetes, and their heart rate effect is consistent but modest. In the SUSTAIN-6 trial (N=3,297), semaglutide 1.0 mg weekly produced a mean HR increase of 2.5 bpm compared to placebo at 104 weeks [16]. The LEADER trial (N=9,340) showed liraglutide increased HR by approximately 3 bpm [17].

The mechanism is not fully characterized. Proposed pathways include direct sinoatrial node GLP-1 receptor activation and indirect sympathetic modulation. A 2 to 4 bpm shift is unlikely to produce symptoms in most patients. It could, however, confound interpretation of RHR trends in someone tracking heart rate as an autonomic fitness marker, particularly if baseline HR is already in the 75 to 85 bpm range [18]. For patients on both a GLP-1 agonist and a beta-blocker, the two effects partially cancel, making RHR even harder to interpret as a standalone metric.

Recreational and Over-the-Counter Substances

Caffeine raises resting heart rate by 3 to 5 bpm at typical intake (200 to 400 mg/day), though habitual users develop tolerance [19]. A single dose of 400 mg in caffeine-naive individuals may produce increases of 8 to 15 bpm per a systematic review in Food and Chemical Toxicology published through the European Food Safety Authority findings [19].

Nicotine, whether smoked or vaped, acutely raises HR by 10 to 15 bpm through catecholamine release. This effect lasts 20 to 30 minutes after each exposure. In heavy smokers, baseline HR is approximately 7 bpm higher than matched non-smokers according to data from the Framingham Heart Study cohort [20].

Alcohol has a biphasic effect. Acute moderate intake (1 to 2 drinks) may lower HR transiently through vasodilation. Binge consumption or chronic heavy use raises resting HR through autonomic dysfunction. A Danish cohort study (N=55,000) found that consuming more than 14 drinks per week was associated with a resting HR increase of 4 to 5 bpm and a significantly higher incidence of atrial fibrillation [21].

Ephedra-containing supplements, though banned by the FDA in 2004, still appear in products marketed for weight loss. They raise HR by 5 to 12 bpm on average and have been associated with serious cardiovascular events [22].

How to Get an Accurate Resting Heart Rate While on Medication

Consistency matters more than any single reading. The American Heart Association recommends measuring RHR first thing in the morning, after at least five minutes of seated or supine rest, before caffeine, and ideally at the same time each day [23]. For patients on chronotropic medications, additional steps improve reliability.

Document every active medication, including OTC drugs, supplements, and nicotine use. Record the time of last dose relative to the HR measurement. Beta-blockers and calcium channel blockers have peak effects 2 to 4 hours post-dose, so a pre-dose trough reading and a post-dose peak reading tell different stories. Stimulant medications (methylphenidate, amphetamine) reach peak plasma levels 1 to 3 hours after oral dosing [10].

For longitudinal tracking, keep medication timing constant. A morning reading taken 12 hours after the last dose of metoprolol will be 8 to 12 bpm higher than one taken 2 hours after the same dose. Comparing those two readings as a "trend" would be misleading.

Wearable devices (Apple Watch, Fitbit, WHOOP, Oura) measure overnight RHR during sleep, which partially controls for acute substance effects but does not eliminate pharmacologic influences. A patient on 50 mg of metoprolol succinate will have a lower overnight HR than their unmedicated baseline regardless of how still they are while sleeping.

Dr. Nieca Goldberg, clinical associate professor of medicine at NYU Grossman School of Medicine and medical director of Atria New York City, has stated: "A resting heart rate is only as useful as the context around it. Without knowing what medications someone is on, that number can be very misleading for both the patient and the clinician."

When Drug-Induced Heart Rate Changes Signal a Problem

Not every drug-related HR change is benign. Beta-blocker toxicity can produce symptomatic bradycardia below 45 bpm with hypotension and syncope. The ACC/AHA guidelines on bradycardia recommend evaluation when resting HR drops below 50 bpm with symptoms such as dizziness, fatigue, or exercise intolerance [24].

On the tachycardia side, drug-induced resting HR above 100 bpm warrants investigation. Causes include thyroid overreplacement, stimulant dose escalation, anticholinergic accumulation (especially in older adults on multiple offending medications), and substance use. The American College of Cardiology notes that persistent sinus tachycardia above 90 bpm at rest, even in the absence of symptoms, is associated with increased cardiovascular mortality in population studies [2].

Specific red flags include: resting HR above 120 bpm with palpitations (possible stimulant toxicity or thyrotoxicosis), new irregular rhythm with HR above 100 (possible atrial fibrillation from thyroid overreplacement or alcohol excess), and HR below 40 bpm with lightheadedness (possible beta-blocker or digoxin toxicity requiring dose adjustment or temporary pacing) [24].

A pharmacist-led medication review is one of the most underused tools for patients with unexplained RHR changes. Cross-referencing the complete medication list against known chronotropic effects takes 15 minutes and may prevent unnecessary cardiac workup.

Normal Resting Heart Rate Range and What Shifts It Beyond Drugs

The standard adult reference range is 60 to 100 bpm. The AHA considers this range a screening guideline, not a diagnostic boundary [23]. Trained endurance athletes routinely register 35 to 50 bpm without pathology.

Non-pharmacologic factors that shift RHR include aerobic fitness (lower with training), age (slight increase in sedentary adults after age 60), ambient temperature, hydration status, acute illness or infection, anxiety, and chronic conditions such as anemia, heart failure, or hyperthyroidism [25]. A fever of 38.5°C (101.3°F) will raise HR by approximately 8 to 10 bpm through thermoregulatory mechanisms alone.

Dr. Michael Emery, co-director of the Sports Cardiology Center at Cleveland Clinic, has noted: "We see athletes whose resting heart rate climbs from 48 to 62 overnight because of a developing upper respiratory infection, not because of any medication change. Context is everything."

The clinical value of RHR lies in longitudinal trends, not isolated snapshots. A patient whose RHR rises from 68 to 84 over three months deserves investigation, but only after accounting for every medication started, stopped, or dose-adjusted during that window.